nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Pain localised—Docetaxel—melanoma	0.0408	0.0519	CcSEcCtD
Sotalol—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.0216	0.0274	CcSEcCtD
Sotalol—Paralysis—Vemurafenib—melanoma	0.0199	0.0253	CcSEcCtD
Sotalol—Colitis ischaemic—Docetaxel—melanoma	0.016	0.0204	CcSEcCtD
Sotalol—Altered state of consciousness—Temozolomide—melanoma	0.0153	0.0195	CcSEcCtD
Sotalol—Isoprenaline—MAPK1—melanoma	0.0132	0.363	CrCbGaD
Sotalol—Pain in extremity—Vemurafenib—melanoma	0.01	0.0128	CcSEcCtD
Sotalol—Eosinophilia—Vemurafenib—melanoma	0.0086	0.0109	CcSEcCtD
Sotalol—Photosensitivity reaction—Vemurafenib—melanoma	0.00793	0.0101	CcSEcCtD
Sotalol—Neuropathy peripheral—Vemurafenib—melanoma	0.00759	0.00965	CcSEcCtD
Sotalol—Coordination abnormal—Carmustine—melanoma	0.00745	0.00948	CcSEcCtD
Sotalol—Coordination abnormal—Temozolomide—melanoma	0.0072	0.00916	CcSEcCtD
Sotalol—Heartburn—Docetaxel—melanoma	0.00684	0.00869	CcSEcCtD
Sotalol—Disorientation—Bleomycin—melanoma	0.0068	0.00865	CcSEcCtD
Sotalol—Throat sore—Docetaxel—melanoma	0.00653	0.0083	CcSEcCtD
Sotalol—Oropharyngeal discomfort—Docetaxel—melanoma	0.00647	0.00823	CcSEcCtD
Sotalol—Angiopathy—Vemurafenib—melanoma	0.00631	0.00802	CcSEcCtD
Sotalol—Cerebrovascular accident—Bleomycin—melanoma	0.00621	0.0079	CcSEcCtD
Sotalol—Alopecia—Vemurafenib—melanoma	0.00614	0.00781	CcSEcCtD
Sotalol—Ibuprofen—BCL2—melanoma	0.00611	0.168	CrCbGaD
Sotalol—Dysgeusia—Vemurafenib—melanoma	0.00593	0.00754	CcSEcCtD
Sotalol—Back pain—Vemurafenib—melanoma	0.00585	0.00744	CcSEcCtD
Sotalol—Lethargy—Dactinomycin—melanoma	0.00579	0.00737	CcSEcCtD
Sotalol—Vascular purpura—Temozolomide—melanoma	0.00574	0.0073	CcSEcCtD
Sotalol—Amnesia—Carmustine—melanoma	0.00566	0.00719	CcSEcCtD
Sotalol—Eye irritation—Docetaxel—melanoma	0.00551	0.00701	CcSEcCtD
Sotalol—Amnesia—Temozolomide—melanoma	0.00547	0.00695	CcSEcCtD
Sotalol—Purpura—Temozolomide—melanoma	0.00533	0.00678	CcSEcCtD
Sotalol—Cough—Vemurafenib—melanoma	0.00528	0.00671	CcSEcCtD
Sotalol—Bronchospasm—Bleomycin—melanoma	0.00518	0.00658	CcSEcCtD
Sotalol—Oropharyngeal pain—Docetaxel—melanoma	0.00517	0.00658	CcSEcCtD
Sotalol—Myalgia—Vemurafenib—melanoma	0.00515	0.00655	CcSEcCtD
Sotalol—Affect lability—Temozolomide—melanoma	0.00505	0.00643	CcSEcCtD
Sotalol—Infection—Vemurafenib—melanoma	0.00491	0.00624	CcSEcCtD
Sotalol—Ibuprofen—CXCL8—melanoma	0.0049	0.135	CrCbGaD
Sotalol—Mood swings—Temozolomide—melanoma	0.00486	0.00619	CcSEcCtD
Sotalol—Acute coronary syndrome—Bleomycin—melanoma	0.00462	0.00588	CcSEcCtD
Sotalol—Hypotension—Vemurafenib—melanoma	0.00461	0.00587	CcSEcCtD
Sotalol—Myocardial infarction—Bleomycin—melanoma	0.0046	0.00585	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0045	0.00572	CcSEcCtD
Sotalol—Abdominal distension—Temozolomide—melanoma	0.00447	0.00568	CcSEcCtD
Sotalol—Decreased appetite—Vemurafenib—melanoma	0.00429	0.00546	CcSEcCtD
Sotalol—Fatigue—Vemurafenib—melanoma	0.00426	0.00541	CcSEcCtD
Sotalol—Haemoglobin—Bleomycin—melanoma	0.00423	0.00538	CcSEcCtD
Sotalol—Haemorrhage—Bleomycin—melanoma	0.00421	0.00536	CcSEcCtD
Sotalol—Lightheadedness—Docetaxel—melanoma	0.00421	0.00535	CcSEcCtD
Sotalol—Pulmonary oedema—Docetaxel—melanoma	0.00419	0.00532	CcSEcCtD
Sotalol—Hyperglycaemia—Carmustine—melanoma	0.00414	0.00527	CcSEcCtD
Sotalol—Upper respiratory tract infection—Temozolomide—melanoma	0.00412	0.00525	CcSEcCtD
Sotalol—Depression—Carmustine—melanoma	0.00408	0.00519	CcSEcCtD
Sotalol—Agranulocytosis—Dactinomycin—melanoma	0.00408	0.00519	CcSEcCtD
Sotalol—Photosensitivity reaction—Temozolomide—melanoma	0.00405	0.00515	CcSEcCtD
Sotalol—Neuropathy peripheral—Carmustine—melanoma	0.00401	0.0051	CcSEcCtD
Sotalol—Hyperglycaemia—Temozolomide—melanoma	0.004	0.00509	CcSEcCtD
Sotalol—Depression—Temozolomide—melanoma	0.00395	0.00502	CcSEcCtD
Sotalol—Body temperature increased—Vemurafenib—melanoma	0.0039	0.00496	CcSEcCtD
Sotalol—Neuropathy peripheral—Temozolomide—melanoma	0.00388	0.00493	CcSEcCtD
Sotalol—Alopecia—Bleomycin—melanoma	0.00372	0.00473	CcSEcCtD
Sotalol—Haemoglobin—Carmustine—melanoma	0.00369	0.0047	CcSEcCtD
Sotalol—Haemorrhage—Carmustine—melanoma	0.00368	0.00467	CcSEcCtD
Sotalol—Visual disturbance—Docetaxel—melanoma	0.0036	0.00458	CcSEcCtD
Sotalol—Haemoglobin—Temozolomide—melanoma	0.00357	0.00454	CcSEcCtD
Sotalol—Haemorrhage—Temozolomide—melanoma	0.00355	0.00452	CcSEcCtD
Sotalol—Asthenia—Vemurafenib—melanoma	0.00354	0.00451	CcSEcCtD
Sotalol—Visual impairment—Carmustine—melanoma	0.00354	0.0045	CcSEcCtD
Sotalol—Cardiac failure—Docetaxel—melanoma	0.0035	0.00445	CcSEcCtD
Sotalol—Pruritus—Vemurafenib—melanoma	0.00349	0.00444	CcSEcCtD
Sotalol—Lethargy—Docetaxel—melanoma	0.00348	0.00443	CcSEcCtD
Sotalol—Alopecia—Dactinomycin—melanoma	0.00347	0.00441	CcSEcCtD
Sotalol—Visual impairment—Temozolomide—melanoma	0.00342	0.00435	CcSEcCtD
Sotalol—Pain in extremity—Docetaxel—melanoma	0.00341	0.00434	CcSEcCtD
Sotalol—Ibuprofen—PPARG—melanoma	0.00339	0.0932	CrCbGaD
Sotalol—Diarrhoea—Vemurafenib—melanoma	0.00338	0.0043	CcSEcCtD
Sotalol—Arrhythmia—Carmustine—melanoma	0.00328	0.00418	CcSEcCtD
Sotalol—Leukopenia—Bleomycin—melanoma	0.00328	0.00417	CcSEcCtD
Sotalol—Dizziness—Vemurafenib—melanoma	0.00327	0.00415	CcSEcCtD
Sotalol—Alopecia—Carmustine—melanoma	0.00325	0.00413	CcSEcCtD
Sotalol—Angiopathy—Temozolomide—melanoma	0.00322	0.0041	CcSEcCtD
Sotalol—Cough—Bleomycin—melanoma	0.0032	0.00407	CcSEcCtD
Sotalol—Vomiting—Vemurafenib—melanoma	0.00314	0.00399	CcSEcCtD
Sotalol—Alopecia—Temozolomide—melanoma	0.00314	0.00399	CcSEcCtD
Sotalol—Chest pain—Bleomycin—melanoma	0.00312	0.00397	CcSEcCtD
Sotalol—Myalgia—Bleomycin—melanoma	0.00312	0.00397	CcSEcCtD
Sotalol—Rash—Vemurafenib—melanoma	0.00311	0.00396	CcSEcCtD
Sotalol—Dermatitis—Vemurafenib—melanoma	0.00311	0.00396	CcSEcCtD
Sotalol—Back pain—Carmustine—melanoma	0.0031	0.00394	CcSEcCtD
Sotalol—Headache—Vemurafenib—melanoma	0.00309	0.00393	CcSEcCtD
Sotalol—Cramp muscle—Docetaxel—melanoma	0.00307	0.00391	CcSEcCtD
Sotalol—Leukopenia—Dactinomycin—melanoma	0.00306	0.00389	CcSEcCtD
Sotalol—Dysgeusia—Temozolomide—melanoma	0.00303	0.00385	CcSEcCtD
Sotalol—Vision blurred—Carmustine—melanoma	0.00302	0.00384	CcSEcCtD
Sotalol—Oedema—Bleomycin—melanoma	0.00299	0.0038	CcSEcCtD
Sotalol—Back pain—Temozolomide—melanoma	0.00299	0.0038	CcSEcCtD
Sotalol—Infection—Bleomycin—melanoma	0.00297	0.00378	CcSEcCtD
Sotalol—Nausea—Vemurafenib—melanoma	0.00293	0.00373	CcSEcCtD
Sotalol—Thrombocytopenia—Bleomycin—melanoma	0.00293	0.00373	CcSEcCtD
Sotalol—Vision blurred—Temozolomide—melanoma	0.00291	0.00371	CcSEcCtD
Sotalol—Myalgia—Dactinomycin—melanoma	0.00291	0.0037	CcSEcCtD
Sotalol—Bronchospasm—Docetaxel—melanoma	0.0029	0.00369	CcSEcCtD
Sotalol—Angina pectoris—Docetaxel—melanoma	0.00287	0.00366	CcSEcCtD
Sotalol—Leukopenia—Carmustine—melanoma	0.00286	0.00364	CcSEcCtD
Sotalol—Hypotension—Bleomycin—melanoma	0.0028	0.00356	CcSEcCtD
Sotalol—Oedema—Dactinomycin—melanoma	0.00279	0.00355	CcSEcCtD
Sotalol—Vertigo—Temozolomide—melanoma	0.00278	0.00353	CcSEcCtD
Sotalol—Infection—Dactinomycin—melanoma	0.00277	0.00353	CcSEcCtD
Sotalol—Leukopenia—Temozolomide—melanoma	0.00277	0.00352	CcSEcCtD
Sotalol—Hypertension—Carmustine—melanoma	0.00276	0.00351	CcSEcCtD
Sotalol—Palpitations—Temozolomide—melanoma	0.00273	0.00348	CcSEcCtD
Sotalol—Thrombocytopenia—Dactinomycin—melanoma	0.00273	0.00347	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Bleomycin—melanoma	0.00273	0.00347	CcSEcCtD
Sotalol—Myalgia—Carmustine—melanoma	0.00272	0.00346	CcSEcCtD
Sotalol—Chest pain—Carmustine—melanoma	0.00272	0.00346	CcSEcCtD
Sotalol—Atenolol—ABCB1—melanoma	0.00272	0.0749	CrCbGaD
Sotalol—Anxiety—Carmustine—melanoma	0.00271	0.00345	CcSEcCtD
Sotalol—Cough—Temozolomide—melanoma	0.0027	0.00343	CcSEcCtD
Sotalol—Paraesthesia—Bleomycin—melanoma	0.00269	0.00342	CcSEcCtD
Sotalol—Hypertension—Temozolomide—melanoma	0.00267	0.0034	CcSEcCtD
Sotalol—Dyspnoea—Bleomycin—melanoma	0.00267	0.00339	CcSEcCtD
Sotalol—Myalgia—Temozolomide—melanoma	0.00263	0.00335	CcSEcCtD
Sotalol—Anxiety—Temozolomide—melanoma	0.00262	0.00334	CcSEcCtD
Sotalol—Oedema—Carmustine—melanoma	0.00261	0.00332	CcSEcCtD
Sotalol—Decreased appetite—Bleomycin—melanoma	0.0026	0.00331	CcSEcCtD
Sotalol—Infection—Carmustine—melanoma	0.00259	0.0033	CcSEcCtD
Sotalol—Acute coronary syndrome—Docetaxel—melanoma	0.00259	0.0033	CcSEcCtD
Sotalol—Myocardial infarction—Docetaxel—melanoma	0.00258	0.00328	CcSEcCtD
Sotalol—Neuropathy peripheral—Docetaxel—melanoma	0.00258	0.00328	CcSEcCtD
Sotalol—Pain—Bleomycin—melanoma	0.00256	0.00325	CcSEcCtD
Sotalol—Thrombocytopenia—Carmustine—melanoma	0.00256	0.00325	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00254	0.00323	CcSEcCtD
Sotalol—Oedema—Temozolomide—melanoma	0.00252	0.00321	CcSEcCtD
Sotalol—Infection—Temozolomide—melanoma	0.00251	0.00319	CcSEcCtD
Sotalol—Thrombocytopenia—Temozolomide—melanoma	0.00247	0.00314	CcSEcCtD
Sotalol—Agranulocytosis—Docetaxel—melanoma	0.00246	0.00312	CcSEcCtD
Sotalol—Hypotension—Carmustine—melanoma	0.00244	0.0031	CcSEcCtD
Sotalol—Hyperhidrosis—Temozolomide—melanoma	0.00244	0.0031	CcSEcCtD
Sotalol—Decreased appetite—Dactinomycin—melanoma	0.00243	0.00308	CcSEcCtD
Sotalol—Fatigue—Dactinomycin—melanoma	0.00241	0.00306	CcSEcCtD
Sotalol—Pain—Dactinomycin—melanoma	0.00239	0.00303	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Carmustine—melanoma	0.00238	0.00303	CcSEcCtD
Sotalol—Haemoglobin—Docetaxel—melanoma	0.00237	0.00302	CcSEcCtD
Sotalol—Body temperature increased—Bleomycin—melanoma	0.00237	0.00301	CcSEcCtD
Sotalol—Haemorrhage—Docetaxel—melanoma	0.00236	0.003	CcSEcCtD
Sotalol—Insomnia—Carmustine—melanoma	0.00236	0.003	CcSEcCtD
Sotalol—Paraesthesia—Carmustine—melanoma	0.00235	0.00298	CcSEcCtD
Sotalol—Dyspnoea—Carmustine—melanoma	0.00233	0.00296	CcSEcCtD
Sotalol—Somnolence—Carmustine—melanoma	0.00232	0.00295	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Temozolomide—melanoma	0.0023	0.00292	CcSEcCtD
Sotalol—Insomnia—Temozolomide—melanoma	0.00228	0.0029	CcSEcCtD
Sotalol—Gastrointestinal pain—Dactinomycin—melanoma	0.00228	0.0029	CcSEcCtD
Sotalol—Visual impairment—Docetaxel—melanoma	0.00228	0.0029	CcSEcCtD
Sotalol—Decreased appetite—Carmustine—melanoma	0.00227	0.00289	CcSEcCtD
Sotalol—Paraesthesia—Temozolomide—melanoma	0.00227	0.00288	CcSEcCtD
Sotalol—Dyspnoea—Temozolomide—melanoma	0.00225	0.00286	CcSEcCtD
Sotalol—Somnolence—Temozolomide—melanoma	0.00224	0.00285	CcSEcCtD
Sotalol—Pain—Carmustine—melanoma	0.00223	0.00284	CcSEcCtD
Sotalol—Dyspepsia—Temozolomide—melanoma	0.00222	0.00283	CcSEcCtD
Sotalol—Abdominal pain—Dactinomycin—melanoma	0.00221	0.00281	CcSEcCtD
Sotalol—Body temperature increased—Dactinomycin—melanoma	0.00221	0.00281	CcSEcCtD
Sotalol—Decreased appetite—Temozolomide—melanoma	0.00219	0.00279	CcSEcCtD
Sotalol—Fatigue—Temozolomide—melanoma	0.00218	0.00277	CcSEcCtD
Sotalol—Pain—Temozolomide—melanoma	0.00216	0.00274	CcSEcCtD
Sotalol—Asthenia—Bleomycin—melanoma	0.00215	0.00273	CcSEcCtD
Sotalol—Angiopathy—Docetaxel—melanoma	0.00214	0.00273	CcSEcCtD
Sotalol—Gastrointestinal pain—Carmustine—melanoma	0.00214	0.00272	CcSEcCtD
Sotalol—Metoprolol—ABCB1—melanoma	0.00212	0.0584	CrCbGaD
Sotalol—Pruritus—Bleomycin—melanoma	0.00212	0.00269	CcSEcCtD
Sotalol—Arrhythmia—Docetaxel—melanoma	0.00211	0.00268	CcSEcCtD
Sotalol—Alopecia—Docetaxel—melanoma	0.00209	0.00265	CcSEcCtD
Sotalol—Abdominal pain—Carmustine—melanoma	0.00206	0.00263	CcSEcCtD
Sotalol—Body temperature increased—Carmustine—melanoma	0.00206	0.00263	CcSEcCtD
Sotalol—Gastrointestinal pain—Temozolomide—melanoma	0.00206	0.00262	CcSEcCtD
Sotalol—Dysgeusia—Docetaxel—melanoma	0.00201	0.00256	CcSEcCtD
Sotalol—Asthenia—Dactinomycin—melanoma	0.002	0.00255	CcSEcCtD
Sotalol—Abdominal pain—Temozolomide—melanoma	0.002	0.00254	CcSEcCtD
Sotalol—Body temperature increased—Temozolomide—melanoma	0.002	0.00254	CcSEcCtD
Sotalol—Back pain—Docetaxel—melanoma	0.00199	0.00253	CcSEcCtD
Sotalol—Muscle spasms—Docetaxel—melanoma	0.00198	0.00251	CcSEcCtD
Sotalol—Diarrhoea—Dactinomycin—melanoma	0.00191	0.00243	CcSEcCtD
Sotalol—Vomiting—Bleomycin—melanoma	0.0019	0.00242	CcSEcCtD
Sotalol—Rash—Bleomycin—melanoma	0.00189	0.0024	CcSEcCtD
Sotalol—Dermatitis—Bleomycin—melanoma	0.00188	0.0024	CcSEcCtD
Sotalol—Asthenia—Carmustine—melanoma	0.00187	0.00238	CcSEcCtD
Sotalol—Syncope—Docetaxel—melanoma	0.00184	0.00235	CcSEcCtD
Sotalol—Leukopenia—Docetaxel—melanoma	0.00184	0.00234	CcSEcCtD
Sotalol—Palpitations—Docetaxel—melanoma	0.00182	0.00231	CcSEcCtD
Sotalol—Asthenia—Temozolomide—melanoma	0.00181	0.0023	CcSEcCtD
Sotalol—Loss of consciousness—Docetaxel—melanoma	0.00181	0.0023	CcSEcCtD
Sotalol—Cough—Docetaxel—melanoma	0.00179	0.00228	CcSEcCtD
Sotalol—Diarrhoea—Carmustine—melanoma	0.00179	0.00227	CcSEcCtD
Sotalol—Pruritus—Temozolomide—melanoma	0.00179	0.00227	CcSEcCtD
Sotalol—Nausea—Bleomycin—melanoma	0.00178	0.00226	CcSEcCtD
Sotalol—Hypertension—Docetaxel—melanoma	0.00178	0.00226	CcSEcCtD
Sotalol—Vomiting—Dactinomycin—melanoma	0.00177	0.00226	CcSEcCtD
Sotalol—Rash—Dactinomycin—melanoma	0.00176	0.00224	CcSEcCtD
Sotalol—Myalgia—Docetaxel—melanoma	0.00175	0.00223	CcSEcCtD
Sotalol—Chest pain—Docetaxel—melanoma	0.00175	0.00223	CcSEcCtD
Sotalol—Dizziness—Carmustine—melanoma	0.00173	0.0022	CcSEcCtD
Sotalol—Diarrhoea—Temozolomide—melanoma	0.00173	0.0022	CcSEcCtD
Sotalol—Oedema—Docetaxel—melanoma	0.00168	0.00213	CcSEcCtD
Sotalol—Dizziness—Temozolomide—melanoma	0.00167	0.00212	CcSEcCtD
Sotalol—Infection—Docetaxel—melanoma	0.00167	0.00212	CcSEcCtD
Sotalol—Vomiting—Carmustine—melanoma	0.00166	0.00211	CcSEcCtD
Sotalol—Nausea—Dactinomycin—melanoma	0.00166	0.00211	CcSEcCtD
Sotalol—Shock—Docetaxel—melanoma	0.00165	0.0021	CcSEcCtD
Sotalol—Rash—Carmustine—melanoma	0.00165	0.00209	CcSEcCtD
Sotalol—Dermatitis—Carmustine—melanoma	0.00165	0.00209	CcSEcCtD
Sotalol—Thrombocytopenia—Docetaxel—melanoma	0.00164	0.00209	CcSEcCtD
Sotalol—Headache—Carmustine—melanoma	0.00164	0.00208	CcSEcCtD
Sotalol—Vomiting—Temozolomide—melanoma	0.0016	0.00204	CcSEcCtD
Sotalol—Rash—Temozolomide—melanoma	0.00159	0.00202	CcSEcCtD
Sotalol—Dermatitis—Temozolomide—melanoma	0.00159	0.00202	CcSEcCtD
Sotalol—Headache—Temozolomide—melanoma	0.00158	0.00201	CcSEcCtD
Sotalol—Hypotension—Docetaxel—melanoma	0.00157	0.00199	CcSEcCtD
Sotalol—Nausea—Carmustine—melanoma	0.00155	0.00197	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Docetaxel—melanoma	0.00153	0.00194	CcSEcCtD
Sotalol—Insomnia—Docetaxel—melanoma	0.00152	0.00193	CcSEcCtD
Sotalol—Paraesthesia—Docetaxel—melanoma	0.00151	0.00192	CcSEcCtD
Sotalol—Nausea—Temozolomide—melanoma	0.0015	0.00191	CcSEcCtD
Sotalol—Dyspnoea—Docetaxel—melanoma	0.0015	0.0019	CcSEcCtD
Sotalol—Somnolence—Docetaxel—melanoma	0.00149	0.0019	CcSEcCtD
Sotalol—Dyspepsia—Docetaxel—melanoma	0.00148	0.00188	CcSEcCtD
Sotalol—Decreased appetite—Docetaxel—melanoma	0.00146	0.00186	CcSEcCtD
Sotalol—Fatigue—Docetaxel—melanoma	0.00145	0.00184	CcSEcCtD
Sotalol—Pain—Docetaxel—melanoma	0.00144	0.00183	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—melanoma	0.00143	0.0393	CrCbGaD
Sotalol—Gastrointestinal pain—Docetaxel—melanoma	0.00137	0.00175	CcSEcCtD
Sotalol—Abdominal pain—Docetaxel—melanoma	0.00133	0.00169	CcSEcCtD
Sotalol—Body temperature increased—Docetaxel—melanoma	0.00133	0.00169	CcSEcCtD
Sotalol—Ibuprofen—ALB—melanoma	0.00127	0.0351	CrCbGaD
Sotalol—Ibuprofen—ABCB1—melanoma	0.00122	0.0334	CrCbGaD
Sotalol—Asthenia—Docetaxel—melanoma	0.0012	0.00153	CcSEcCtD
Sotalol—Pruritus—Docetaxel—melanoma	0.00119	0.00151	CcSEcCtD
Sotalol—Diarrhoea—Docetaxel—melanoma	0.00115	0.00146	CcSEcCtD
Sotalol—Dizziness—Docetaxel—melanoma	0.00111	0.00141	CcSEcCtD
Sotalol—Vomiting—Docetaxel—melanoma	0.00107	0.00136	CcSEcCtD
Sotalol—Rash—Docetaxel—melanoma	0.00106	0.00135	CcSEcCtD
Sotalol—Dermatitis—Docetaxel—melanoma	0.00106	0.00134	CcSEcCtD
Sotalol—Headache—Docetaxel—melanoma	0.00105	0.00134	CcSEcCtD
Sotalol—Nausea—Docetaxel—melanoma	0.000997	0.00127	CcSEcCtD
Sotalol—ADRB1—GPCR downstream signaling—GNAQ—melanoma	0.000172	0.000972	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCR4—melanoma	0.000171	0.000962	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KISS1—melanoma	0.000169	0.000952	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GNAQ—melanoma	0.000169	0.000951	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNA11—melanoma	0.000168	0.00095	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GAB2—melanoma	0.000168	0.00095	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000168	0.000947	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KISS1—melanoma	0.000165	0.000931	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GAB2—melanoma	0.000165	0.000929	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNA11—melanoma	0.000165	0.000929	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—HRAS—melanoma	0.000165	0.000929	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000164	0.000926	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR1—melanoma	0.000163	0.000922	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SKI—melanoma	0.000163	0.000922	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MC1R—melanoma	0.000161	0.000908	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR1—melanoma	0.00016	0.000902	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SKI—melanoma	0.00016	0.000902	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT3—melanoma	0.000159	0.000897	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCR4—melanoma	0.000158	0.000893	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MC1R—melanoma	0.000158	0.000889	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GNAQ—melanoma	0.000157	0.000883	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT3—melanoma	0.000156	0.000878	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCR4—melanoma	0.000155	0.000874	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GRM1—melanoma	0.000154	0.000871	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCR7—melanoma	0.000154	0.000871	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GNAQ—melanoma	0.000153	0.000864	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GRM1—melanoma	0.000151	0.000852	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCR7—melanoma	0.000151	0.000852	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SUFU—melanoma	0.00015	0.000849	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SUFU—melanoma	0.000147	0.00083	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT3—melanoma	0.000145	0.000815	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT3—melanoma	0.000141	0.000797	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RHOB—melanoma	0.00014	0.000792	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BCL2L11—melanoma	0.00014	0.000792	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RHOB—melanoma	0.000137	0.000775	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BCL2L11—melanoma	0.000137	0.000775	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HDAC6—melanoma	0.000135	0.000761	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—EDN1—melanoma	0.000134	0.000754	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HDAC6—melanoma	0.000132	0.000745	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—EDN1—melanoma	0.000131	0.000738	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CSF2—melanoma	0.000131	0.000737	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR2—melanoma	0.000128	0.000722	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL8—melanoma	0.000128	0.000721	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CSF2—melanoma	0.000128	0.000721	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RAC2—melanoma	0.000126	0.00071	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PRKCA—melanoma	0.000125	0.000707	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR2—melanoma	0.000125	0.000706	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL8—melanoma	0.000125	0.000705	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFC—melanoma	0.000124	0.000699	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—WNT5A—melanoma	0.000124	0.000699	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RAC2—melanoma	0.000123	0.000694	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCA—melanoma	0.000123	0.000691	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EDN1—melanoma	0.000121	0.000685	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—WNT5A—melanoma	0.000121	0.000684	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFC—melanoma	0.000121	0.000684	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EDN1—melanoma	0.000119	0.00067	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CSF2—melanoma	0.000119	0.000669	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—RAC1—melanoma	0.000116	0.000655	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CSF2—melanoma	0.000116	0.000655	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCA—melanoma	0.000114	0.000642	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—RAC1—melanoma	0.000114	0.000641	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKCA—melanoma	0.000111	0.000628	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAP2K2—melanoma	0.000111	0.000627	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAP2K2—melanoma	0.000109	0.000614	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—F2R—melanoma	0.000109	0.000614	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—F2R—melanoma	0.000106	0.0006	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RAC1—melanoma	0.000105	0.000595	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDNRB—melanoma	0.000105	0.000594	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RAC1—melanoma	0.000103	0.000582	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDNRB—melanoma	0.000103	0.000581	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTK2B—melanoma	0.000102	0.000577	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTK2B—melanoma	0.0001	0.000564	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNA11—melanoma	9.95e-05	0.000561	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GAB2—melanoma	9.95e-05	0.000561	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FLT1—melanoma	9.91e-05	0.000559	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	9.81e-05	0.000553	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GAB2—melanoma	9.73e-05	0.000549	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNA11—melanoma	9.73e-05	0.000549	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FLT1—melanoma	9.69e-05	0.000547	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	9.6e-05	0.000541	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR4—melanoma	9.35e-05	0.000528	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FOXO4—melanoma	9.35e-05	0.000528	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HDAC2—melanoma	9.35e-05	0.000528	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GNAQ—melanoma	9.25e-05	0.000522	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FOXO4—melanoma	9.15e-05	0.000516	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HDAC2—melanoma	9.15e-05	0.000516	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR4—melanoma	9.15e-05	0.000516	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GNAQ—melanoma	9.05e-05	0.00051	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	8.91e-05	0.000503	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	8.72e-05	0.000492	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SYK—melanoma	8.7e-05	0.00049	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	8.63e-05	0.000487	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ITGAV—melanoma	8.54e-05	0.000481	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT3—melanoma	8.54e-05	0.000481	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NGFR—melanoma	8.54e-05	0.000481	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SYK—melanoma	8.51e-05	0.00048	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	8.44e-05	0.000476	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT3—melanoma	8.35e-05	0.000471	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ITGAV—melanoma	8.35e-05	0.000471	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NGFR—melanoma	8.35e-05	0.000471	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SOCS1—melanoma	7.9e-05	0.000446	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	7.89e-05	0.000445	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—S100B—melanoma	7.88e-05	0.000445	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	7.83e-05	0.000442	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SOCS1—melanoma	7.73e-05	0.000436	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	7.71e-05	0.000435	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—S100B—melanoma	7.71e-05	0.000435	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	7.66e-05	0.000432	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB4—melanoma	7.54e-05	0.000425	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	7.52e-05	0.000424	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN2B—melanoma	7.47e-05	0.000422	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB4—melanoma	7.38e-05	0.000416	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	7.36e-05	0.000415	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN2B—melanoma	7.31e-05	0.000412	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD86—melanoma	7.23e-05	0.000408	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	7.23e-05	0.000408	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDN1—melanoma	7.17e-05	0.000405	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD86—melanoma	7.07e-05	0.000399	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	7.07e-05	0.000399	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDN1—melanoma	7.02e-05	0.000396	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF1—melanoma	7.01e-05	0.000395	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CSF2—melanoma	7.01e-05	0.000395	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IL2—melanoma	6.91e-05	0.000389	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—E2F1—melanoma	6.86e-05	0.000387	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CSF2—melanoma	6.86e-05	0.000387	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF1—melanoma	6.86e-05	0.000387	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	6.83e-05	0.000385	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFRA—melanoma	6.79e-05	0.000383	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2—melanoma	6.76e-05	0.000381	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ITGB3—melanoma	6.72e-05	0.000379	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCA—melanoma	6.72e-05	0.000379	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—E2F1—melanoma	6.71e-05	0.000378	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	6.68e-05	0.000377	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFRA—melanoma	6.64e-05	0.000375	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SPP1—melanoma	6.59e-05	0.000372	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ITGB3—melanoma	6.57e-05	0.000371	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCA—melanoma	6.57e-05	0.000371	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAP2K2—melanoma	6.57e-05	0.000371	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL8—melanoma	6.56e-05	0.00037	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SPP1—melanoma	6.45e-05	0.000364	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAP2K2—melanoma	6.43e-05	0.000362	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL8—melanoma	6.42e-05	0.000362	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2—melanoma	6.27e-05	0.000354	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TERT—melanoma	6.25e-05	0.000352	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RAC1—melanoma	6.23e-05	0.000351	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2—melanoma	6.13e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TERT—melanoma	6.11e-05	0.000345	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RAC1—melanoma	6.1e-05	0.000344	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIF1A—melanoma	5.98e-05	0.000337	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIF1A—melanoma	5.85e-05	0.00033	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KDR—melanoma	5.71e-05	0.000322	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KDR—melanoma	5.59e-05	0.000315	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FN1—melanoma	5.5e-05	0.00031	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH1—melanoma	5.38e-05	0.000304	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FN1—melanoma	5.38e-05	0.000303	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD80—melanoma	5.27e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH1—melanoma	5.27e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APC—melanoma	5.26e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—melanoma	5.26e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KIT—melanoma	5.26e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—NRAS—melanoma	5.26e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGF—melanoma	5.2e-05	0.000293	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD80—melanoma	5.16e-05	0.000291	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KIT—melanoma	5.15e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APC—melanoma	5.15e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—melanoma	5.15e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—NRAS—melanoma	5.15e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGF—melanoma	5.09e-05	0.000287	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAPK3—melanoma	5.04e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BRAF—melanoma	4.95e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAPK3—melanoma	4.93e-05	0.000278	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BRAF—melanoma	4.84e-05	0.000273	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—melanoma	4.82e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAPK1—melanoma	4.8e-05	0.000271	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EGFR—melanoma	4.8e-05	0.00027	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—melanoma	4.71e-05	0.000266	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAPK1—melanoma	4.69e-05	0.000265	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EGFR—melanoma	4.69e-05	0.000265	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAP2K1—melanoma	4.66e-05	0.000263	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CD—melanoma	4.63e-05	0.000261	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	4.58e-05	0.000259	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAP2K1—melanoma	4.56e-05	0.000257	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—KRAS—melanoma	4.53e-05	0.000256	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CD—melanoma	4.53e-05	0.000255	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	4.48e-05	0.000253	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—KRAS—melanoma	4.43e-05	0.00025	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF2—melanoma	4.43e-05	0.00025	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF2—melanoma	4.33e-05	0.000244	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	4.16e-05	0.000235	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MDM2—melanoma	4.15e-05	0.000234	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB2—melanoma	4.09e-05	0.000231	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	4.07e-05	0.00023	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MDM2—melanoma	4.06e-05	0.000229	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CB—melanoma	4.03e-05	0.000228	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB2—melanoma	4e-05	0.000226	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CB—melanoma	3.95e-05	0.000223	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL8—melanoma	3.88e-05	0.000219	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HRAS—melanoma	3.85e-05	0.000217	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL8—melanoma	3.79e-05	0.000214	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1B—melanoma	3.79e-05	0.000214	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HRAS—melanoma	3.77e-05	0.000212	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—melanoma	3.74e-05	0.000211	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP3—melanoma	3.71e-05	0.000209	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2—melanoma	3.7e-05	0.000209	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1B—melanoma	3.7e-05	0.000209	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—melanoma	3.69e-05	0.000208	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—melanoma	3.66e-05	0.000207	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP3—melanoma	3.63e-05	0.000205	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2—melanoma	3.62e-05	0.000204	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCND1—melanoma	3.61e-05	0.000204	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—melanoma	3.61e-05	0.000203	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CTNNB1—melanoma	3.58e-05	0.000202	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCND1—melanoma	3.53e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—melanoma	3.51e-05	0.000198	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CTNNB1—melanoma	3.5e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1A—melanoma	3.49e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTEN—melanoma	3.49e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NFKB1—melanoma	3.47e-05	0.000196	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—melanoma	3.43e-05	0.000193	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1A—melanoma	3.42e-05	0.000193	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTEN—melanoma	3.41e-05	0.000192	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—melanoma	3.4e-05	0.000192	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NFKB1—melanoma	3.39e-05	0.000191	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—melanoma	3.33e-05	0.000188	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—melanoma	3.15e-05	0.000178	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—melanoma	3.12e-05	0.000176	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRAS—melanoma	3.11e-05	0.000175	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—melanoma	3.08e-05	0.000174	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—melanoma	3.05e-05	0.000172	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRAS—melanoma	3.04e-05	0.000172	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK3—melanoma	2.98e-05	0.000168	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK3—melanoma	2.91e-05	0.000164	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—melanoma	2.9e-05	0.000163	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK1—melanoma	2.83e-05	0.00016	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—melanoma	2.83e-05	0.00016	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGFR—melanoma	2.83e-05	0.00016	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK1—melanoma	2.77e-05	0.000156	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGFR—melanoma	2.77e-05	0.000156	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KRAS—melanoma	2.68e-05	0.000151	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KRAS—melanoma	2.62e-05	0.000148	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.46e-05	0.000139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CA—melanoma	2.41e-05	0.000136	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TP53—melanoma	2.38e-05	0.000134	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TP53—melanoma	2.33e-05	0.000131	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HRAS—melanoma	2.28e-05	0.000128	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HRAS—melanoma	2.23e-05	0.000126	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—melanoma	2.18e-05	0.000123	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—melanoma	2.13e-05	0.00012	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—melanoma	2.01e-05	0.000113	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—melanoma	1.97e-05	0.000111	CbGpPWpGaD
